Josep Bassaganya-Riera
Chief Executive Officer at Biotherapeutics, Inc.
Josep Bassaganya-Riera active positions
| Companies | Position | Start | End |
|---|---|---|---|
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Chief Executive Officer | - | - |
| Chairman | - | - | |
| Founder | 2007-12-31 | - | |
| President | - | - | |
| Nutritional Immunology & Molecular Medicine Laboratory | Director/Board Member | 2002-06-30 | - |
| Chief Executive Officer | 2002-06-30 | - | |
| Founder | 2002-06-30 | - | |
| President | 2002-06-30 | - |
Career history of Josep Bassaganya-Riera
Former positions of Josep Bassaganya-Riera
| Companies | Position | Start | End |
|---|---|---|---|
| LANDOS BIOPHARMA, INC. | Chief Executive Officer | 2016-12-31 | 2021-11-05 |
| Chairman | 2016-12-31 | 2021-11-05 | |
| Founder | 2016-12-31 | 2021-11-05 | |
| President | 2016-12-31 | 2021-11-05 | |
| Virginia Polytechnic Institute & State University | Corporate Officer/Principal | - | - |
Training of Josep Bassaganya-Riera
| Universitat Autònoma de Barcelona | Undergraduate Degree |
| Iowa State University | Doctorate Degree |
Statistics
International
| United States | 6 |
| Spain | 2 |
Operational
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 3 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
| Nutritional Immunology & Molecular Medicine Laboratory |
